Global Syphilis Immunoassay Diagnostics Market Report 2022: Rising Rate of Abortions, Stillbirth, and other Abnormalities During Pregnancy Driving Growth – ResearchAndMarkets.com

Global Syphilis Immunoassay Diagnostics Market Report 2022: Rising Rate of Abortions, Stillbirth, and other Abnormalities During Pregnancy Driving Growth – ResearchAndMarkets.com




Global Syphilis Immunoassay Diagnostics Market Report 2022: Rising Rate of Abortions, Stillbirth, and other Abnormalities During Pregnancy Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Syphilis Immunoassay Diagnostics Market (2022-2027) by Product, Technology, End-user, and Geography, with Competitive Analysis, Impact of COVID-19, and Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering.

The Global Syphilis Immunoassay Diagnostics Market is estimated to be worth USD 318 million in 2022, and is expected to reach USD 475.31 million by 2027, growing at a CAGR of 8.37%.

Market Segmentation

The Global Syphilis Immunoassay Diagnostics Market is segmented based on Product, Technology, End-user, and Geography.

  • By Product, the market is classified into Analyzers, and Kits & Reagents.
  • By Technology, the market is classified into ELISA, CLIA, and Others.
  • By End-user, the market is classified into Hospitals, Diagnostic Labs, Blood Banks, and Others.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies’ recent development and competitive scenario. Some of the companies covered in this report are Abbott Laboratories, Becton, Dickinson, and Company, Bio-Rad Laboratories, Danaher (Beckman Coulter), Roche, Siemens Healthineers, etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

The Competitive Quadrant

The report includes the Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global Syphilis Immunoassay Diagnostics Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
  • The Global Syphilis Immunoassay Diagnostics Market is analyzed using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, suitable strategies have been devised for market growth.

Market Dynamics

Drivers

  • Rising Prevalence of Syphilis Infection Due to Unprotected Sex
  • Government Reforms Targeted Towards the Betterment of Healthcare Infrastructure
  • Chances of Mother-to-Child Gestational Syphilis

Restraints

  • Asymptomatic Disease, and Problems in Diagnosing Very Early Syphilis

Opportunities

  • Widespread Use of Technology for Testing
  • Rising Rate of Abortions, Stillbirth, and other Abnormalities During Pregnancy
  • Availability of Rapid, Automated Treponemal Tests and On-the-Spot Testing Solutions

Challenges

  • Lack of Awareness of Syphilis Immunoassay Disease

Key Topics Covered:

1 Report Description

2 Research Methodology

3 Executive Summary

4 Market Dynamics

5 Market Analysis

6 Global Syphilis Immunoassay Diagnostics Market, by Product

7 Global Syphilis Immunoassay Diagnostics Market, by Technology

8 Global Syphilis Immunoassay Diagnostics Market, by End User

9 Americas’ Syphilis Immunoassay Diagnostics Market

10 Europe’s Syphilis Immunoassay Diagnostics Market

11 Middle East and Africa’s Syphilis Immunoassay Diagnostics Market

12 APAC’s Syphilis Immunoassay Diagnostics Market

13 Competitive Landscape

14 Company Profiles

15 Appendix

Companies Mentioned

  • Abbott Laboratories
  • Beckman Coulter
  • Becton, Dickinson, and Company
  • bioMerieux
  • Bio-Rad Laboratories
  • Danaher (Beckman Coulter)
  • DiaSorin
  • Fujirebio (Miraca Group)
  • Gold Standard Diagnostics
  • Newmarket Biomedical
  • NuGenerex Diagnostics
  • Ortho Clinical Diagnostics (Carlyle Group)
  • Roche
  • Shenzhen New Industries Biomedical Engineering
  • Siemens Healthineers

For more information about this report visit https://www.researchandmarkets.com/r/9d3u5w

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900